NCT00229333

Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia

Exploratory Study to Assess the Efficacy of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia and Mixed Vascular and Alzheimer's Dementia

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (planned)
• Sponsor: Sheba Medical Center · Other Government
• Sex: All
• Age: 60 Years
• Healthy volunteers: Not accepted

Summary

The goal of the present study is to compare the effectiveness of the active (S)-enantiomer of citalopram, escitalopram with placebo in the treatment of patients with depressive syndrome complicating Alzheimer's dementia (AD), vascular dementia (VD) or mixed dementia (MD), for 8 weeks of double-blind treatment.

Conditions

• Depressive Syndrome

Interventions

Type	Name	Description
DRUG	Escitalopram

Timeline

• Start date: 2004-12-01
• First posted: 2005-09-29
• Last updated: 2006-08-29

Locations

1 site across 1 country: Israel